Alembic Pharmaceuticals Dividende

Zukünftiges Wachstum Kriterienprüfungen 4/6

Alembic Pharmaceuticals ist ein dividendenzahlendes Unternehmen mit einer aktuellen Rendite von 0.98%, die durch die Erträge gut gedeckt ist.

Wichtige Informationen

1.0%

Dividendenausschüttung

35%

Ausschüttungsquote

Durchschnittlicher Branchenertrag0.7%
Nächster Dividendenzahlungsterminn/a
Ex-Dividendendatumn/a
Dividende pro Aktie₹11.000
Gewinn pro Aktie₹32.05
Zukünftige Dividendenrendite1.5%

Aktuelle Dividendenentwicklung

Recent updates

Alembic Pharmaceuticals Limited's (NSE:APLLTD) Intrinsic Value Is Potentially 17% Below Its Share Price

Sep 25
Alembic Pharmaceuticals Limited's (NSE:APLLTD) Intrinsic Value Is Potentially 17% Below Its Share Price

Is Alembic Pharmaceuticals (NSE:APLLTD) Using Too Much Debt?

Sep 03
Is Alembic Pharmaceuticals (NSE:APLLTD) Using Too Much Debt?

Alembic Pharmaceuticals Limited Earnings Missed Analyst Estimates: Here's What Analysts Are Forecasting Now

Aug 13
Alembic Pharmaceuticals Limited Earnings Missed Analyst Estimates: Here's What Analysts Are Forecasting Now

Market Participants Recognise Alembic Pharmaceuticals Limited's (NSE:APLLTD) Earnings Pushing Shares 25% Higher

Jul 20
Market Participants Recognise Alembic Pharmaceuticals Limited's (NSE:APLLTD) Earnings Pushing Shares 25% Higher

Alembic Pharmaceuticals (NSE:APLLTD) Seems To Use Debt Rather Sparingly

Jun 03
Alembic Pharmaceuticals (NSE:APLLTD) Seems To Use Debt Rather Sparingly

Does This Valuation Of Alembic Pharmaceuticals Limited (NSE:APLLTD) Imply Investors Are Overpaying?

May 11
Does This Valuation Of Alembic Pharmaceuticals Limited (NSE:APLLTD) Imply Investors Are Overpaying?

Results: Alembic Pharmaceuticals Limited Exceeded Expectations And The Consensus Has Updated Its Estimates

Feb 08
Results: Alembic Pharmaceuticals Limited Exceeded Expectations And The Consensus Has Updated Its Estimates

Subdued Growth No Barrier To Alembic Pharmaceuticals Limited (NSE:APLLTD) With Shares Advancing 25%

Jan 21
Subdued Growth No Barrier To Alembic Pharmaceuticals Limited (NSE:APLLTD) With Shares Advancing 25%

Is Alembic Pharmaceuticals (NSE:APLLTD) A Risky Investment?

Jan 05
Is Alembic Pharmaceuticals (NSE:APLLTD) A Risky Investment?

Here's Why Alembic Pharmaceuticals (NSE:APLLTD) Can Manage Its Debt Responsibly

Sep 27
Here's Why Alembic Pharmaceuticals (NSE:APLLTD) Can Manage Its Debt Responsibly

Alembic Pharmaceuticals (NSE:APLLTD) Seems To Use Debt Quite Sensibly

Jun 09
Alembic Pharmaceuticals (NSE:APLLTD) Seems To Use Debt Quite Sensibly

A Look At The Fair Value Of Alembic Pharmaceuticals Limited (NSE:APLLTD)

Apr 13
A Look At The Fair Value Of Alembic Pharmaceuticals Limited (NSE:APLLTD)

Is Alembic Pharmaceuticals (NSE:APLLTD) A Risky Investment?

Feb 22
Is Alembic Pharmaceuticals (NSE:APLLTD) A Risky Investment?

Alembic Pharmaceuticals Limited (NSE:APLLTD) Shares Could Be 21% Below Their Intrinsic Value Estimate

Jan 04
Alembic Pharmaceuticals Limited (NSE:APLLTD) Shares Could Be 21% Below Their Intrinsic Value Estimate

We Think Shareholders Are Less Likely To Approve A Large Pay Rise For Alembic Pharmaceuticals Limited's (NSE:APLLTD) CEO For Now

Nov 05
We Think Shareholders Are Less Likely To Approve A Large Pay Rise For Alembic Pharmaceuticals Limited's (NSE:APLLTD) CEO For Now

Here's Why Alembic Pharmaceuticals (NSE:APLLTD) Has A Meaningful Debt Burden

Aug 10
Here's Why Alembic Pharmaceuticals (NSE:APLLTD) Has A Meaningful Debt Burden

Estimating The Intrinsic Value Of Alembic Pharmaceuticals Limited (NSE:APLLTD)

Jul 20
Estimating The Intrinsic Value Of Alembic Pharmaceuticals Limited (NSE:APLLTD)

We Think Alembic Pharmaceuticals (NSE:APLLTD) Is Taking Some Risk With Its Debt

May 05
We Think Alembic Pharmaceuticals (NSE:APLLTD) Is Taking Some Risk With Its Debt

Stabilität und Wachstum des Zahlungsverkehrs

Rufe Dividendendaten ab

Stabile Dividende: APLLTDDie Dividendenzahlungen des Unternehmens waren in den vergangenen 10 Jahren volatil.

Wachsende Dividende: APLLTDDie Dividendenzahlungen des Unternehmens sind in den letzten 10 Jahren gestiegen.


Dividendenrendite im Vergleich zum Markt

Alembic Pharmaceuticals Dividendenrendite im Vergleich zum Markt
Wie sieht die Dividendenrendite von APLLTD im Vergleich zum Markt aus?
SegmentDividendenrendite
Unternehmen (APLLTD)1.0%
Untere 25 % des Marktes (IN)0.2%
Markt Top 25 % (IN)1.1%
Branchendurchschnitt (Pharmaceuticals)0.7%
Analystenprognose (APLLTD) (bis zu 3 Jahre)1.5%

Bemerkenswerte Dividende: APLLTDDie Dividende des Unternehmens (0.98%) ist höher als die der untersten 25% der Dividendenzahler auf dem Indian Markt (0.24%).

Hohe Dividende: APLLTDDie Dividende des Unternehmens (0.98%) ist im Vergleich zu den besten 25% der Dividendenzahler auf dem Markt Indian (1.08%) niedrig.


Gewinnausschüttung an die Aktionäre

Abdeckung der Erträge: Mit einer relativ niedrigen Ausschüttungsquote (35.1%) sind die Dividendenzahlungen von APLLTD gut durch die Erträge gedeckt.


Barausschüttung an die Aktionäre

Cashflow-Deckung: Mit einer relativ niedrigen Ausschüttungsquote (45.5%) sind die Dividendenzahlungen von APLLTD durch den Cashflow gut gedeckt.


Entdecken Sie dividendenstarke Unternehmen